| Exosomal lncRNAs as new players in cell-to-cell communication |
36 |
| Downregulation of hexokinase 2 improves radiosensitivity of breast cancer |
16 |
| The role of deep learning and radiomic feature extraction in cancer-specific predictive modelling: a review |
12 |
| Circular RNAs and competing endogenous RNA (ceRNA) networks |
12 |
| EGFR first- and second-generation TKIs-there is still place for them in EGFR-mutant NSCLC patients |
9 |
| Exosomes as critical mediators of cell-to-cell communication in cancer pathogenesis and their potential clinical application |
8 |
| EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: a case report and literature review |
7 |
| Expression and prognostic value of PD-L1 and PD-L2 in ovarian cancer |
7 |
| New techniques for sentinel node biopsy in breast cancer |
6 |
| The future is now: beyond first line systemic therapy in hepatocellular carcinoma |
6 |
| Plasma fibrinogen as prognostic predictor in patients with metastatic renal cell carcinoma receiving target therapy |
5 |
| Identification of potential gene and microRNA biomarkers for colon cancer by an integrated bioinformatical approach |
5 |
| An update in breast cancer management for elderly patients |
5 |
| Long non-coding RNAs in non-small cell lung cancer: functions and distinctions from other malignancies |
5 |
| Androgen deprivation therapy and radiation therapy for prostate cancer: the mechanism underlying therapeutic synergy |
5 |
| Detection of microRNAs in circulating tumor cells |
5 |
| Methods for quantification and characterization of microRNAs in cell-free plasma/serum, normal exosomes and tumor-derived exosomes |
5 |
| Circulating exosomes and their cargos in blood as novel biomarkers for cancer |
4 |
| Canonical and selective approaches in exosome purification and their implications for diagnostic accuracy |
4 |
| The proteomic comparison of peripheral circulation-derived exosomes from the epithelial ovarian carcinoma (EOC) patients and non-EOC subjects |
4 |
| Utilization of combined PD-L1 expression and neutrophil-to-lymphocyte ratio prior to surgery as a prognostic factor in non-small cell lung cancer with brain metastasis |
4 |
| Clinical relevance of liquid biopsy for cancer screening |
4 |
| Is liquid biopsy ready for the litmus test and what has been achieved so far to deal with pre-analytical issues? |
4 |
| An observational study of vascular endothelial growth factor inhibitors as second-line treatment for metastatic colorectal cancer treated with bevacizumab plus FOLFIRI beyond progression: the association with RAS mutation and tumor sidedness |
4 |
| Predictive value of preoperative weight loss on survival of elderly patients undergoing surgery for esophageal squamous cell carcinoma |
4 |
| Clinical significance of serum tumor markers for advanced gastric cancer with the first-line chemotherapy |
4 |
| A radiomics nomogram for preoperatively predicting prognosis of patients in hepatocellular carcinoma |
4 |
| Therapeutic potential of molecular hydrogen in ovarian cancer |
4 |
| Alcohol intake patterns for cancer and non-cancer individuals: a population study |
4 |
| Metformin prolonged the survival of diffuse large B-cell lymphoma and grade 3b follicular lymphoma patients responding to first-line treatment with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone: a prospective phase II clinical trial |
4 |
| Knowledge and attitudes towards low dose computed tomography lung cancer screening and smoking among African Americans-a mixed method study |
4 |
| Bioinformatics-based identification of differentiated expressed microRNA in esophageal squamous cell carcinoma |
4 |
| Detection of circulating stage III-IV gastric cancer tumor cells based on isolation by size of epithelial tumor: using the circulating tumor cell biopsy technology |
3 |
| Reduced RANBP9 expression is associated with poor prognosis in colorectal cancer patients |
3 |
| Application of Bayesian predictive probability for interim futility analysis in single-arm phase II trial |
3 |
| Tumor immunotherapy-the potential of epigenetic drugs to overcome resistance |
3 |
| Preoperative chemoradiation may be more effective for esophageal squamous cell carcinoma compared with adenocarcinoma: results from 15 randomized controlled trials of 250 patients |
3 |
| In-vitro evaluation of HSP27 inhibitors function through HER2 pathway for ovarian cancer therapy |
3 |
| MiR-875-5p inhibits hepatocellular carcinoma cell proliferation and migration by repressing astrocyte elevated gene-1 (AEG-1) expression |
3 |
| The relative biological effectiveness of proton and carbon ion beams in photon-sensitive and resistant nasopharyngeal cancer cells |
3 |
| Overexpression of the long non-coding RNA BLACAT1 promotes cell proliferation and invasion in colorectal cancer |
3 |
| Potential predictive value of JAK2 expression for Pan-cancer response to PD-1 blockade immunotherapy |
3 |
| The necessity of adjuvant radiotherapy for locally advanced gastric cancer in China |
3 |
| Rutin induces apoptosis via P53 up-regulation in human glioma CHME cells |
3 |
| Identification of potential therapeutic targets in hepatocellular carcinoma using an integrated bioinformatics approach |
3 |
| Circulating DNA-based lung cancer diagnostics and follow-up: looking for epigenetic markers |
3 |
| TGF-beta signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types |
3 |
| Prostate-specific membrane antigen in prostate cancer imaging and treatment |
3 |
| Hypofractionation in prostate cancer radiotherapy |
3 |
| Wnt/beta-catenin signaling pathway is involved in induction of apoptosis by oridonin in colon cancer COLO205 cells |
3 |
